The tight interaction with the IRF1/survivin or survivin/SMAD3 complexes maintains expression of IFN-sensitive genes that are clinically relevant in several autoimmune diseases, including RA,48,64 systemic lupus erythematosus,49 and Sjögren’s syndrome.50 This evidence concerns the gene IRF1 and rheumatoid arthritis.